Abstract
The chapter describes the main clinical scenarios leading to graft failure/dysfunction in heart recipients and provides clinical contextualization for pathologists required to identify the possible main underlying causes.
We summarize clinical definitions and presentations of early/late and acute/chronic graft dysfunction and donor or recipient factors that can influence their development and different aetiologies, which typically vary during the course of post-transplant follow-up.
Because clinical presentation of graft dysfunction is usually not aetiology-specific, we also discuss the role of endomyocardial biopsy (EMB) in defining aetiology, in relation to acute or chronic presentation.
The different role of EMB when performed in scheduled protocols or in presence of a systolic or diastolic graft dysfunction is also thoroughly treated and the spectrum of myocardial inflammation findings to evaluate and interpret in heart transplant patients is described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. PROCEED II trial investigators. Lancet. 2015;385(9987):2577–84.
Badano LP, Miglioranza MH, Edvardsen T, Colafranceschi AS, Muraru D, Bacal F, Nieman K, Zoppellaro G, Marcondes Braga FG, Binder T, Habib G, Lancellotti P. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Eur Heart J Cardiovasc Imaging. 2015;16(9):919–48.
Billingham M, Cary N, Hammond E. A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Lung Transplant. 1990;8:587–93.
Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res. 2009;83(2):247–61.
Boilson BA, Miller DV, Pereira NL. Late allograft failure after heart transplantation: 2 unusual cases. J Heart Lung Transplant. 2008;27(9):1050–4.
Butler J, Stankewicz MA, Wu J, et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant. 2005;24:170–7.
Oto T, Excell L, Griffiths AP, Levvey BJ, Bailey M, Marasco S, Macdonald P, Snell P, Snell GI. Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor. Am J Transplant. 2008;8(10):2132–9.
Caves PK, Stinson EB, Billingham ME, Shumway NE. Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet. 1974;1(7862):821–6.
Cheng R, Azarbal B, Yung A, Chang DH, Patel JK, Kobashigawa JA. Elevated immune monitoring early after cardiac transplantation is associated with increased plaque progression by intravascular ultrasound. Clin Transplant. 2015;29(2):103–9.
Cosio C, Gomez Bueno M, Almenar L, Delgado JF, Arizon JM, Gonzalez Vilchez F, Crespo-Leiro MG, Mirabet S, Roig E, Perez Villa F, Fernandez-Yanez JF, Lambert JL, Manito N, Fuente L, Sanz Julve ML, Pascual D, Rabago G, Millan I, Alonso-Pulpon LA, Segovia J. Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score. J Heart Lung Transplant. 2013;32(12):1187–95.
Fedrigo M, Leone O, Burke MM, Rice A, Toquet C, Vernerey D, Frigo AC, Guillemain R, Pattier S, Smith J, Lota A, Potena L, Bontadini A, Ceccarelli C, Poli F, Feltrin G, Gerosa G, Manzan E, Thiene G, Bruneval P, Angelini A, Duong Van Huyen JP. Am J Transplant. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP. 2015;15(2):526–34.
Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar N. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Transplantation. 2014;97(12):1240–6.
Hicks M, Hing A, Gao L, Ryan J, Macdonald PS. Organ preservation. Methods Mol Biol. 2006;333:331–74.
Hiemann NE, Wellnhofer E, Knosalla C, Lehmkuhl HB, Stein J, Hetzer R, Meyer R. Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies. Circulation. 2007;116(11):1274–82.
Kfoury AG, Stehlik J, Renlund DG, et al. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant. 2006;25:1277–82.
Khush KK, Kubo JT, Desai M. Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant. 2012;31(5):459–66.
Kobashigawa J, Crespo-Leiro MG, Ensminger SM, et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2011;30(3):252–69.
Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M, Mancini D, Patel J, Razi R, Reichenspurner H, Russell S, Segovia J, Smedira N, Stehlik J, Wagner F, Consensus Conference participants. Report from a consensus conference of primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant. 2014;33(4):327–40.
Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Goldfarb SB, Levvey BJ, Meiser B, Yusen RD, Stehlik J. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report – 2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33(10):996–1008.
Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010;29:717–27.
Michaels PJ, Espejo ML, Kobashigawa JA, et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003;22:58–69.
Mohamedali B, Bhat G, Tatooles A, Zelinger A. Neurogenic stress cardiomyopathy in heart donors. J Cardiac Fail. 2014;20:207–11.
Nair N, Ball T, Uber PA, Mehra MR. Current and future challenges in therapy for antibody-mediated rejection. J Heart Lung Transplant. 2011;30(6):612–7.
Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 2006;82(11):1396–401.
Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg. 2007;84(5):1556–62; discussion 1562–3.
Potena L, Bontadini A, Iannelli S, Fruet F, Leone O, Barberini F, Borgese L, Manfredini V, Masetti M, Magnani G, Fallani F, Grigioni F, Branzi A. Occurrence of fatal and nonfatal adverse outcomes after heart transplantation in patients with pretransplant noncytotoxic HLA antibodies. J Transplant. 2013;2013:519680.
Potena L, Masetti M, Sabatino M, Bacchi-Reggiani ML, Pece V, Prestinenzi P, Dall'Ara G, Taglieri N, Saia F, Fallani F, Magnani G, Rapezzi C, Grigioni F. Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation. J Heart Lung Transplant. 2015;34(9):146–53.
Russo MJ, Iribarne A, Hong KN, et al. Factors associated with primary graft failure after heart transplantation. Transplantation. 2010;90:444–50.
Sellares J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12(2):388–99.
Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe CC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24(11):1710–20.
Tang Z, Kobashigawa J, Rafiei M, Stern LK, Hamilton M. The natural history of biopsy-negative rejection after heart transplantation. J Transplant. 2013;2013:236720.
White M, Wiechmann RJ, Roden RL, Hagan MB, Wollmering MM, Port JD, Hammond E, Abraham WT, Wolfel EE, Lindenfeld J, et al. Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation. 1995;92(8):2183–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Potena, L., Manfredini, V., Leone, O. (2016). Graft Failure/Dysfunction: Clinical Issues and Role of Endomyocardial Biopsy. In: Leone, O., Angelini, A., Bruneval, P., Potena, L. (eds) The Pathology of Cardiac Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-46386-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-46386-5_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46384-1
Online ISBN: 978-3-319-46386-5
eBook Packages: MedicineMedicine (R0)